APA

Tanaka J., Iwao N., Toubai T., Tsutsumi Y., Miura Y., Kato N., Shigematsu A., Yamane M., Ota S., Kondo T., Kobayashi T., Takeda H., Kobayashi M., Asaka M. & Imamura M. (20050329). Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. : Leukemia.

Chicago

Tanaka J, Iwao N, Toubai T, Tsutsumi Y, Miura Y, Kato N, Shigematsu A, Yamane M, Ota S, Kondo T, Kobayashi T, Takeda H, Kobayashi M, Asaka M and Imamura M. 20050329. Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. : Leukemia.

Harvard

Tanaka J., Iwao N., Toubai T., Tsutsumi Y., Miura Y., Kato N., Shigematsu A., Yamane M., Ota S., Kondo T., Kobayashi T., Takeda H., Kobayashi M., Asaka M. and Imamura M. (20050329). Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. : Leukemia.

MLA

Tanaka J, Iwao N, Toubai T, Tsutsumi Y, Miura Y, Kato N, Shigematsu A, Yamane M, Ota S, Kondo T, Kobayashi T, Takeda H, Kobayashi M, Asaka M and Imamura M. Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. : Leukemia. 20050329.